Pfizer Inc. (NYSE:PFE ) Full-Year 2025 Financial Guidance Conference Call December 17, 2024 8:30 AM ET Company Participants Francesca DeMartino - Chief IRO and SVP Albert Bourla - Chairman and CEO Dav
Pfizer (PFE) shares rose Tuesday morning after the pharmaceutical company affirmed its full-year 2024 projections and issued 2025 revenue and adjusted profit guidance in line with analysts' estimates.
Vamil Divan, Guggenheim Securities analyst, joins 'Squawk on the Street' to discuss Pfizer's guidance, how optimistic Divan is on Pfizer's product pipeline, and some of the complaints Pfizer has heard
Pharma stocks Pfizer Inc (NYSE:PFE) and Teva Pharmaceutical Industries Ltd (NYSE:TEVA) are in the spotlight today.
Pfizer Inc (NYSE:PFE, ETR:PFE) shares ticked up on Tuesday after the pharmaceutical giant appeared to offer relief for investors with guidance for the coming year. Revenue should grow by up to 5% nex
On Tuesday, Pfizer Inc. PFE released its full-year 2025 financial guidance, projecting revenues between $61.0 billion and $64.0 billion compared to a consensus of $63.28 billion.
The company anticipates adjusted earnings of between $2.80 and $3 a share in 2025. Analysts had been expecting adjusted earnings of $2.86.
Drugmaker Pfizer on Tuesday said it was expecting its 2025 profits to be nearly in line with Wall Street expectations as it seeks to fend off criticism over its turnaround strategy from activist hedge
NEW YORK--(BUSINESS WIRE)--Pfizer 2025 Financial Guidance press release.
What's the hottest S&P 500 stock of 2024? Palantir Technologies (PLTR -0.42%) is the hands-down winner.
Pfizer Inc. PFE will conduct an investor call on Tuesday to provide full-year 2025 financial guidance.
Pfizer's shares have significantly underperformed, but the current valuation and high dividend yield present a compelling value play. Despite revenue declines and potential regulatory risks, Pfizer re
Pharmaceutical and biotech stocks often are seen as steady and safe options for investors for one particular reason. Patients need their medications, so regardless of the economic environment, these c

Pfizer: Irrational Anti-Vaccine Fear

10:00am, Sunday, 15'th Dec 2024
Pfizer's stock has become appealing due to irrational vaccine fears. Market fears about RFK Jr.'s potential anti-vaccine stance are likely overblown, as neither he nor Trump have indicated plans to bl

Is Pfizer a Millionaire Maker?

07:53am, Sunday, 15'th Dec 2024
With a market capitalization of more than $143 billion today, Pfizer (PFE 0.83%) stock won't make anyone into a millionaire unless they're willing to commit a large amount of capital and then hold the
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE